Discover the best sectors for growth stocks in the next decade. Explore which sectors may present an opportunity to bolster ...
Global genital herpes treatment market will reach $5,051.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 84 tables and 80 figures, this 168-page report ?Global Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, ...
Dealmaking in the Asia Pacific (APAC) region took off this week, with the latest showcasing Genome & Co.’s licensing deal with Ellipses Pharma Ltd. for GENA-104, a phase I-ready immuno-oncology asset, ...
Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for ...
OliX Pharmaceuticals announced a global licensing agreement with Eli Lilly (LLY). This collaboration focuses on the development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results